Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 14, 2021 - Issue
Submit an article Journal homepage
126
Views
5
CrossRef citations to date
0
Altmetric
Original Research

A Real-World Evaluation of Clinical Outcomes of Biologicals and Bronchial Thermoplasty for Severe Refractory Asthma (BIOTERM)

Francesco Menzella1 Pulmonology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia- IRCCS, Reggio Emilia, 42123, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3950-5789View further author information
ORCID Icon,
Matteo Fontana1 Pulmonology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia- IRCCS, Reggio Emilia, 42123, ItalyView further author information
,
Carla Galeone1 Pulmonology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia- IRCCS, Reggio Emilia, 42123, ItalyView further author information
,
Maria D’Amato2 Department of Pulmonology, AO “Dei Colli” Federico II University, Naples, 80131, ItalyView further author information
,
Giorgio Walter Canonica3 Personalized Medicine, Asthma and Allergy - Humanitas Clinical and Research Center, IRCCS - Rozzano, Milan, ItalyView further author information
,
Giulia Ghidoni1 Pulmonology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia- IRCCS, Reggio Emilia, 42123, ItalyView further author information
,
Silvia Capobelli1 Pulmonology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia- IRCCS, Reggio Emilia, 42123, ItalyView further author information
,
Chiara Scelfo1 Pulmonology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia- IRCCS, Reggio Emilia, 42123, ItalyORCID Iconhttps://orcid.org/0000-0002-3192-3882View further author information
ORCID Icon,
Anna Simonazzi1 Pulmonology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia- IRCCS, Reggio Emilia, 42123, ItalyView further author information
,
Chiara Catellani1 Pulmonology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia- IRCCS, Reggio Emilia, 42123, ItalyView further author information
,
Patrizia Ruggiero1 Pulmonology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia- IRCCS, Reggio Emilia, 42123, ItalyView further author information
&
Nicola Facciolongo1 Pulmonology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia- IRCCS, Reggio Emilia, 42123, ItalyView further author information
 show all
Pages 1019-1031 | Published online: 13 Aug 2021

References

  • Bagnasco D, Passalacqua G, Caminati M, et al. Evolving phenotypes to endotypes: is precision medicine achievable in asthma? Expert Rev Respir Med. 2020;14(2):163–172. doi:10.1080/17476348.2020.1703675
  • Fahy JV. Type 2 inflammation in asthma – present in most, absent in many. Nat Rev Immunol. 2015;15(1):57–65. doi:10.1038/nri3786
  • Menzella F, Ruggiero P, Ghidoni G, et al. Anti-IL5 therapies for severe eosinophilic asthma: literature review and practical insights. J Asthma Allergy. 2020;13:301–313. doi:10.2147/JAA.S258594
  • Menzella F, Lusuardi M, Galeone C, et al. Bronchial thermoplasty and the role of airway smooth muscle: are we on the right direction? Ther Clin Risk Manag. 2017;13:1213–1221. doi:10.2147/TCRM.S144604
  • Thomson NC. Recent developments in bronchial thermoplasty for severe asthma. J Asthma Allergy. 2019;12:375–387. doi:10.2147/JAA.S200912
  • Holguin F, Cardet JC, Chung KF, et al. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2020;55(1):1900588. doi:10.1183/13993003.00588-2019
  • Available from: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf. Accessed May 27, 2021.
  • Bourdin A, Husereau D, Molinari N, et al. Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic review. Eur Respir J. 2018;52(5):1801393. doi:10.1183/13993003.01393-2018
  • Busse W, Chupp G, Nagase H, et al. Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: indirect treatment comparison. J Allergy Clin Immunol. 2019;143(1):190–200.e20. doi:10.1016/j.jaci.2018.08.031
  • Menzella F, Latorre M, Ruggiero P, Bagnasco D, Heffler E. Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy? Expert Opin Biol Ther. 2019;19(7):601–606. doi:10.1080/14712598.2019.1613367
  • Langton D, Sha J, Guo S, et al. Bronchial thermoplasty versus mepolizumab: comparison of outcomes in a severe asthma clinic. Respirology. 2020;25(12):1243–1249. doi:10.1111/resp.13830
  • Castro M, Rubin AS, Laviolette M, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med. 2010;181(2):116–124. doi:10.1164/rccm.200903-0354OC
  • Langton D, Ing A, Fielding D, et al. Safety and effectiveness of bronchial thermoplasty when FEV1 is less than 50. Chest. 2020;157(3):509–515. doi:10.1016/j.chest.2019.08.2193
  • Menzella F, Galeone C, Ruggiero P, Bagnasco D, Catellani C, Facciolongo N. Biologics and bronchial thermoplasty for severe refractory asthma treatment: from eligibility criteria to real practice. A cross-sectional study. Pulm Pharmacol Ther. 2020;60:101874. doi:10.1016/j.pupt.2019.101874
  • Pelaia C, Busceti MT, Crimi C, et al. Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma. Biomed Pharmacother. 2020;129:110444. doi:10.1016/j.biopha.2020.110444
  • Menzella F, Ruggiero P, Galeone C, Scelfo C, Bagnasco D, Facciolongo N. Significant improvement in lung function and asthma control after benralizumab treatment for severe refractory eosinophilic asthma. Pulm Pharmacol Ther. 2020;64:101966. doi:10.1016/j.pupt.2020.101966
  • Siergiejko Z, Świebocka E, Smith N, et al. Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients. Curr Med Res Opin. 2011;27(11):2223–2228. doi:10.1185/03007995.2011.620950
  • Molimard M, Buhl R, Niven R, et al. Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: real-life data. Respir Med. 2010;104(9):1381–1385. doi:10.1016/j.rmed.2010.06.001
  • Pavord ID, Cox G, Thomson NC, et al. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med. 2007;176:1185–1191. doi:10.1164/rccm.200704-571OC
  • Madsen H, Henriksen DP, Backer V, Siersted HC, Bjerring N, Ulrik CS. Efficacy of bronchial thermoplasty in patients with severe asthma. J Asthma. 2019:1–7. doi:10.1080/02770903.2019.1678636
  • NIH. U.S National Library of Medicine. Available from: http://clinicaltrials.gov. Accessed May 2, 2021.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.